Cited by 72Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Plant Pathogen Control

Broad antifungal resistance mediated by RNAi-dependent epimutation in the basal human fungal pathogen Mucor circinelloides

Open access
Chang, Zanetta, Billmyre, R. Blake, Lee, Soo Chan, Heitman, Joseph·2019·PLOS Genetics

Published version of a preprint

Abstract

Mucormycosis-an emergent, deadly fungal infection-is difficult to treat, in part because the causative species demonstrate broad clinical antifungal resistance. However, the mechanisms underlying drug resistance in these infections remain poorly understood. Our previous work demonstrated that one major agent of mucormycosis, Mucor circinelloides, can develop resistance to the antifungal agents FK506 and rapamycin through a novel, transient RNA interference-dependent mechanism known as epimutation. Epimutations silence the drug target gene and are selected by drug exposure; the target gene is re-expressed and sensitivity is restored following passage without drug. This silencing process involves generation of small RNA (sRNA) against the target gene via core RNAi pathway proteins. To further elucidate the role of epimutation in the broad antifungal resistance of Mucor, epimutants were isolated that confer resistance to another antifungal agent, 5-fluoroorotic acid (5-FOA). We identified epimutant strains that exhibit resistance to 5-FOA without mutations in PyrF or PyrG, enzymes which convert 5-FOA into the active toxic form. Using sRNA hybridization as well as sRNA library analysis, we demonstrate that these epimutants harbor sRNA against either pyrF or pyrG, and further show that this sRNA is lost after reversion to drug sensitivity. We conclude that epimutation is a mechanism capable of targeting multiple genes, enabling Mucor to develop resistance to a variety of antifungal agents. Elucidation of the role of RNAi in epimutation affords a fuller understanding of mucormycosis. Furthermore, it improves our understanding of fungal pathogenesis and adaptation to stresses, including the evolution of drug resistance.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pgen.1007957

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In M. circinelloides, RNAi-mediated epimutations can confer antifungal resistance via degradation of mRNAs of drug target genes.

    “In Mucor circinelloides (causative agent of mucormycosis), RNAi (RNA interference)-mediated epimutations can confer antifungal resistance via degradation of mRNAs of drug target genes100,101.”

    From Molecular mechanisms governing antifungal drug resistance (2023) · cites this paper as [100]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Chang, Z., Billmyre, R. B., Lee, S. C., & Heitman, J.
Affiliations
  • Duke University (US)
  • Stowers Institute for Medical Research (US)
Corresponding author
  • Chang, Zanetta
  • Heitman, Joseph
Venue
PLOS Genetics
Published
2019-02-11
Volume
15
Issue
2
Pages
e1007957
ISSN
  • 1553-7390 (ISSN-L)
  • 1553-7404
OpenAlex
W2949320128
Cited by
72
References
56
Citations by year
2026: 7 · 2025: 11 · 2024: 13 · 2023: 10 · 2022: 8 · 2021: 6 · 2020: 12 · 2019: 5
FWCI
5.94
Type
journal article
Language
en
Open access
Locations
  • PLoS Genetics (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Funders
  • Astellas Pharma
  • National Institutes of Health (2r01ai050113-16a1, AI39115, AI39115-21, AI50113, AI50113-15)
  • National Institute of General Medical Sciences (T32GM007171)
  • National Institute of Allergy and Infectious Diseases (R37AI039115, AI39115-21, AI50113-15, AI 39115, AI50113, R01-AI050113, AI104533, P01AI104533)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Life Sciences › Agricultural and Biological Sciences › Ecology, Evolution, Behavior and Systematics › Fungal Plant Pathogen Control
Keywords
Mucor circinelloides, mucormycosis, antifungal resistance, epimutations, RNA interference, small RNA, pyrG, 5-fluoroorotic acid resistance, rapamycin resistance, gene silencing, fungal pathogenesis
MeSH terms
Antifungal Agents, Genes, Fungal, Humans, Mucor, Mucormycosis, Mutation, Orotate Phosphoribosyltransferase, Orotic Acid, Orotidine-5'-Phosphate Decarboxylase, RNA, Fungal, Tacrolimus, Sirolimus, Drug Resistance, Multiple, Fungal, RNA Interference, Epigenesis, Genetic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review